Cerenia

Maropitant , sold under the brand name Cerenia among others, when used as maropitant citrate (USAN), is a neurokinin-1 (NK1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007, for use in dogs and in 2012, for cats. Maropitant mildly reduces intra-procedural inhaled anesthesia dose requirements but does not confer analgesia itself.